Contents

Current Drug Targets - Infectious Disorders, Volume 4 - Number 2

Vaccine Therapy for Hepatitis B Virus Carrier

, 4(2): 93 - 101

Sk. Md. Fazle Akbar, Shinya Furukawa, Norio Horiike and Morikazu Onji


DOI: 10.2174/1568005043340885




Two Orthogonal Approaches to Overcome Multi-Drug Resistant HIV-1s: Development of Protease Inhibitors and Entry Inhibitors Based on CXCR4 Antagonists

, 4(2): 103 - 110

Hirokazu Tamamura and Nobutaka Fujii


DOI: 10.2174/1568005043340957




Antiviral Properties of Quinolone-based Drugs

, 4(2): 111 - 116

Sara Richter, Cristina Parolin, Manlio Palumbo and Giorgio Palu


DOI: 10.2174/1568005043340920




Candida and Candidiasis: The Cell Wall as a Potential Molecular Target for Antifungal Therapy

, 4(2): 117 - 135

Daniel Gozalbo, Patricia Roig, Eva Villamon and Maria Luisa Gil


DOI: 10.2174/1568005043341046




Determining and Overcoming Resistance to HIV Protease Inhibitors

, 4(2): 137 - 152

Jana Prejdova, Milan Soucek and Jan Konvalinka


DOI: 10.2174/1568005043340984




Aminoglycoside Nephrotoxicity

, 4(2): 153 - 162

F. Rougier, D. Claude, M. Maurin and P. Maire


DOI: 10.2174/1568005043340858




Novel Tissue and Cell Type-specific Gene / Drug Delivery System Using Surface Engineered Hepatitis B Virus Nano-particles

, 4(2): 163 - 167

Tadanori Yamada, Masakazu Ueda, Masaharu Seno, Akihiko Kondo, Katsuyuki Tanizawa and Shun'ichi Kuroda


DOI: 10.2174/1568005043341037




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science